Deutsche Bank AG decreased its holdings in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 84.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,918 shares of the electronics maker's stock after selling 46,895 shares during the quarter. Deutsche Bank AG's holdings in Dolby Laboratories were worth $716,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DLB. Alpine Bank Wealth Management acquired a new stake in Dolby Laboratories in the first quarter worth approximately $25,000. Cheviot Value Management LLC acquired a new stake in shares of Dolby Laboratories in the first quarter valued at about $27,000. Global X Japan Co. Ltd. bought a new stake in shares of Dolby Laboratories in the first quarter valued at about $51,000. Fifth Third Bancorp lifted its stake in Dolby Laboratories by 84.7% during the first quarter. Fifth Third Bancorp now owns 665 shares of the electronics maker's stock worth $53,000 after purchasing an additional 305 shares during the period. Finally, UMB Bank n.a. raised its stake in shares of Dolby Laboratories by 170.5% in the first quarter. UMB Bank n.a. now owns 698 shares of the electronics maker's stock valued at $56,000 after acquiring an additional 440 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.
Dolby Laboratories Stock Performance
Shares of NYSE:DLB traded down $0.46 during midday trading on Friday, reaching $71.68. The company's stock had a trading volume of 400,469 shares, compared to its average volume of 473,551. The firm has a market capitalization of $6.87 billion, a price-to-earnings ratio of 26.26 and a beta of 0.91. The firm has a 50 day moving average price of $74.24 and a two-hundred day moving average price of $76.27. Dolby Laboratories has a fifty-two week low of $68.24 and a fifty-two week high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The business had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is 48.35%.
Insider Buying and Selling at Dolby Laboratories
In other news, CEO Kevin J. Yeaman sold 39,875 shares of the firm's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $74.82, for a total value of $2,983,447.50. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,583,724.50. This trade represents a 25.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Shriram Revankar sold 7,000 shares of the firm's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares of the company's stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 148,049 shares of company stock valued at $11,045,581. Company insiders own 38.39% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on DLB shares. Barrington Research restated an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Friday, May 2nd. Tigress Financial increased their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Rosenblatt Securities reaffirmed a "buy" rating and set a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Finally, Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Dolby Laboratories currently has a consensus rating of "Buy" and a consensus target price of $103.00.
Get Our Latest Research Report on DLB
About Dolby Laboratories
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Stories

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.